Medication info
Empitorin Tablet 10/20 mg

Empitorin Tablet 10/20 mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
A white to off-white, bilaterally convex, rectangular tablet.
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201600904 · Approved 2016.02.17 · Insurance code 669906620

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, recommended treatment goal, and response. Administer this drug once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL-cholesterol reduction may start at 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels at intervals of 4 weeks or more and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking 10/80 mg for 12 months or more without evidence of muscle toxicity (see section 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug 10/20mg once daily in the evening. Use caution and monitor closely when administering higher doses to these patients (see section 5. General Precautions under Precautions for Use). Administration in elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See section 6. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia.
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, Apo B, and triglycerides while increasing HDL cholesterol in patients with primary hypercholesterolemia. It can be used in combination with dietary therapy for patients with familial hypercholesterolemia, and can be administered as an adjunct or alternative treatment in patients with homozygous familial hypercholesterolemia. This medication is used as a lipid-modifying agent to reduce the risk of atherosclerotic vascular disease due to hypercholesterolemia. Before use, secondary causes such as diabetes or hypothyroidism should be evaluated and treated if necessary. Furthermore, this medication is administered after appropriate dietary control and non-pharmacological management have been attempted, and it is ineffective. Overall, this medication is used to improve cholesterol and lipid levels to reduce the risk of cardiovascular diseases.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, recommended treatment goal, and response. Administer this drug once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL-cholesterol reduction may start at 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels at intervals of 4 weeks or more and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking 10/80 mg for 12 months or more without evidence of muscle toxicity (see section 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug 10/20mg once daily in the evening. Use caution and monitor closely when administering higher doses to these patients (see section 5. General Precautions under Precautions for Use). Administration in elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See section 6. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medication can cause muscle problems, so if muscle pain or weakness occurs, consult a doctor immediately. Particular caution is needed when taking high doses as the risk of muscle damage increases. Women who are pregnant or nursing and those with allergies to any ingredients in this medication or with active liver disease should not use this medication. Additionally, drugs that interfere with the metabolism of this medication in the liver, such as certain antifungal agents, antibiotics, and antiviral drugs, should not be taken concurrently. This medication may affect liver function, so patients with a history of liver disease should have regular liver function tests. Elderly patients or those with compromised kidney function should be particularly cautious when taking this medication, and dosage adjustments may be necessary. Patients should report any unexplained muscle pain, weakness, or darkening of urine to healthcare providers immediately while taking this medication. The risk of muscle damage may increase when used in combination with other lipid-lowering agents, so caution is warranted during concurrent administration. Women planning to become pregnant should consult a doctor before taking this medication, and they should discontinue its use immediately if pregnancy is confirmed during treatment. This medication should not be administered to breastfeeding women, and if nursing, breastfeeding should be stopped. In children or adolescents, due to limited safety data, it should be taken only under medical supervision. Patients receiving new prescriptions while taking this medication should inform their healthcare providers about all currently taken medications. There is no specific antidote for overdose, so patients should seek appropriate medical treatment immediately. Taking this medication with grapefruit juice may increase blood concentrations, so avoiding grapefruit juice is recommended.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, hepatocellular aminotransferase elevation, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, sensory abnormalities, depression, cholelithiasis, cholecystitis, skin and mucosa syndrome, toxic epidermal necrolysis, eosinophilia, drug reactions with systemic symptoms, erythema multiforme, liver damage, weakness, cataract, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, ocular motility disorders, facial asymmetrical paralysis, tremor, peripheral neuropathy, peripheral nerve paralysis, mental disorders, anxiety, sleep disorders, memory decline, forgetfulness, amnesia, memory impairment, confusion, interstitial lung disease, erythema lupus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, arthritis, photosensitivity, fever, chills, flushing, lethargy, dyspnea, cholestatic jaundice, liver fat change, cirrhosis, fulminant hepatic necrosis, liver cancer, liver failure, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ocular muscle paralysis, anemia, elevated aminotransferases, increased ALP, elevated γ-GT, increased bilirubin levels, thyroid dysfunction, serum creatine kinase increase, abnormal liver function tests, increased HbA1c, elevated fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucus stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

A white to off-white, bilaterally convex, rectangular tablet.

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.